Skip to main content
TipRanks
Go Ultimate75% OFF

John C. Thomas Insider Profile

4 Followers

John C. Thomas, Director at Dogwood Therapeutics, holds ― shares in Dogwood Therapeutics (Ticker: DWTX), holds 263.95K shares in ImmunityBio (Ticker: IBRX), holds 37.00K shares in Novelion Therapeutics (Ticker: NVLNF).

John C. Thomas's Trading History

IBRX
ImmunityBio
Aug 21, 2020DirectorInformative Sell183.80K$1.59M
NVLNF
Novelion Therapeutics
Jul 01, 2015―Informative Buy87.13K$25.97K
DARA
DARA Biosciences
Feb 06, 2012―Uninformative Buy―$8.80K
MDXG
MiMedx Group
―CFO & Secretary―$16.91M
DWTX
Dogwood Therapeutics
―Director――

You May Also Like

John C. Thomas insider profile FAQ

What is the percentage of profitable transactions made by John C. Thomas?
The percentage of profitable transactions made by John C. Thomas is 33%.
What is the average return per transaction made by John C. Thomas?
The average return per transaction made by John C. Thomas is -74.50%.
What stocks does John C. Thomas hold?
John C. Thomas holds: DWTX, NVLNF, IBRX, MDXG, DARA stocks.
What was John C. Thomas's most profitable transaction?
John C. Thomas’s most profitable transaction was an Informative Sell of IBRX stock on November 23, 2016. The return on the trade was 33.10%.
What is John C. Thomas's role in Dogwood Therapeutics?
John C. Thomas's role in Dogwood Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.